Breaking

Pope Francis, voice for the poor who transformed the Catholic Church, dies at 88
This 1,000-mile river suffered decades of oil spills. Now it’s a legal person, things could change
Francis: The ‘outsider’ pope who faced fierce resistance to his reforms
What happens next after Francis’ death? How the Catholic Church will pick a successor
On Ecuador’s cocaine coast, with a fisherman who turned to smuggling
The Kremlin’s 30-hour truce was designed to shift blame to Ukraine. Did Trump buy it?
Meet the US cardinal now running the Vatican
Putin says he’s open to direct talks with Ukraine as US pressure builds

Home
Features
- View All On Demos
Buy Now
Search for:

Investing

Clinical trial data shows RAD 101 detects Brain Metastases

February 10, 2025

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties

Westport Announces Annual General and Special Meeting and Timing of Q1 2025 Financial Results

Gold Price Hits New Record, Breaking US$3,300 for First Time

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (366)
- Investing (1,158)
- Stocks (451)
- World (1,420)

Disclaimer: thecapitalstrategies.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 thecapitalstrategies.com | All Rights Reserved

Top

Type above and press Enter to search. Press Esc to cancel.